Personalized Medicine Convention
The International Event for Personalized Medicine
Cologne // 30.11. + 01.12.2016
Save the Date! 7. PerMediCon, April 18th + 19th 2018, Theater am Tanzbrunnen, Cologne
The Innovative Congress
for personalized medicine
Top-class interdisciplinary discussions in front of an international audience: According to the motto “Redefining Health Care in the Genome Aera” experts from different countries discuss progress and challenges in personalized medicine. Key topic of the two-day congress exhibition of this year is the Genomic Oncology, from particular interest to patient benefit.
The following topics are, among other things, discussed controversially:
What does Genomic Oncology require?
- evidence-based performance controlling
- specialization and centralization
- cross-sectoral cooperation
- new skills for the medical profession
- “Health Literacy“ in the broader public
The exhibition area with numerous enterprise offers plenty of space for networking, personal exchange and detailed specialist discussions.
The scientific program is once again enriched by the “Call for Projects”. Innovative and practical oriented projects products, technologies and services in the context of personalized medicine are presented.
PerMediCon unites three different meeting formats in one event: Congress, Trade Exhibition and Call for Projects. The superordinate objective was to enable participants from different disciplines and therapeutic areas to learn from each other and to form networks in order to facilitate and accelerate the adoption of personalized medicine into medical practice – for the benefit of the patients’ health.
The central challenges and opportunities of personalized medicine will be discussed in an interdisciplinary way by internationally renowned experts.
Representatives from science, research, industry and services as well as from associations and institutions will present their contributions to personalized medicine.
Call for Projects
presents projects related to personalized medicine in the fields of biotechnology, diagnostics, healthcare IT, medical technology and pharmaceuticals
Partnership for the Future
PerMediCon and the Center for Integrated Oncology
For the second time PerMediCon 2016 takes place in cooperation with the Center for Integrated Oncology (CIO) Cologne Bonn and the Center for Genetically Related Breast and Ovarian Cancer.
The Center for Integrated Oncology Cologne Bonn was founded in 2007 and is once again awarded as Top Oncological Centre of the German Cancer Aid since 2008.
In the network of the University Clinics Cologne and Bonn all are working on the diagnosis, treatment and care of patients diagnosed with cancer participating clinics and institutes. The goal is the consistent and steady improvement in the treatment and care of cancer patients.
This is achieved by optimizing the interdisciplinary collaboration of clinical subjects, a comprehensive psycho-oncological care of the patients and by close integration of clinical care with the basic and clinical research. The close links with general practitioners and hospitals is a central concern of the CIO.
Minister of Innovation, Science and Research of the German State of North-Rhine-Westphalia
Key Issue 2016: Genome Oncology
The greatest progress in personalized medicine is the development in oncology. There are already many approved drugs. Hardly a month passes without reports on new, promising drugs. Traditional therapy concepts are on trial. Interdisciplinary approaches are the focus. Therefore clinics and specialist practices need to be adjusted organization to this development by new networks and forms if they want to treat their patients according to the latest research.
As part of the congress - under the scientific leadership of Congress Presidents Prof. Dr. Rita Schmutzler and Prof. Dr. Jürgen Wolf - international experts present latest research findings and innovations in personalized cancer care.
The aim of the congress is to provide the exchange with participating physicians, researchers and clinics to establish the personalized cancer therapy for the future.
In addition, it is also important to position Germany as a location for internationally visible innovation for Health Research.
The target audience of PerMediCon
PerMediCon’s holistic approach serves to address the following target groups:
Doctors, pharmacists, decision-makers
and managers at hospitals
Politics, business, ethics councils, cost-bearers, regulatory bodies, quality assurance
Organisations & interest groups
(trade) associations, patient organisations, clusters, networks, support programmes, public institutions
Industry and service providers
Pharmaceutics, diagnostics/analytics, biotechnology, medical engineering, health IT, clinical research organisations, medical/diagnostics laboratories, consulting, biobanks
Science & research
Universities, technical schools, fundamental research, industry-sponsored research
Videos PerMediCon 2015
PerMediCon 2015 - Messefilm
Leiterin des Beratungsdienstes INFONETZ KREBS der Deutschen Krebshilfe
Dr. Stephan Brock
Chief Technology Officer Molecular Health GmbH
Dr. Werner Eberhardt
Vice President Healthcare Development SAP SE
Dr. Dr. Arne Engelsberg
Medical Team Lead Lung/GI cancer & early development Pfizer Oncology Europe / Africa / Middle East
Prof. Dr. Riccardo Dalla-Favera
Director, Institute for Cancer Genetics Columbia University
Prof. Dr. Randy D. Gascoyne
FRCPC Professor of Pathology of British Columbia Cancer Agency
Prof. Dr. Arnulf H. Hölscher
Direktor der Klinik und Poliklinik für Allgemein-, Viszeral- und Tumorchirurgie Uniklinik Köln
Autorin von "Das Handbuch gegen Krebs"
Prof. Dr. Dr. Kimmo Porkka
Head of Department of Hematology Helsinki University Hospital Comprehensive Cancer Center
Prof. Dr. Edgar Schömig
Vorstandsvorsitzender und Ärztlicher Direktor Uniklinik Köln
See PerMediCon YouTube Channel
Competence Partners 2016